An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer

BACKGROUND: Men with metastatic castration-resistant prostate cancer (mCRPC) are living longer, therefore optimizing health-related quality of life (HRQL), as well as survival outcomes, is important for optimal patient care. The aim of this study was to assess the HRQL in patients with mCRPC receivi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:ESMO Open
Hoofdauteurs: Thiery-Vuillemin, A., Fizazi, K., Sartor, O., Oudard, S., Bury, D., Thangavelu, K., Ozatilgan, A., Poole, E.M., Eisenberger, M., de Bono, J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2021
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7980065/
https://ncbi.nlm.nih.gov/pubmed/33740734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100089
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items